Life Sciences Report – Implications of Brexit

Clinical Professionals and Vacancysoft

Summer 2016

In this report we examine the implications of Brexit for pharmaceutical recruitment. Our key findings are:

  • Concerns over Brexit have yet to translate into a fall in vacancy volumes in biotech
  • However once the pending EU clinical trials regulations take effect from 2017, CROs may come under pressure to move their operations
  • Regulatory costs are set to rise as the UK sets up its own framework
  • If membership of the single market can be retained combined with FTAs with other G20 countries, UK pharma could end up with a unique advantage over competition.

Yes, I want this report!


    Yes, I would like to receive more information about your products, offers, and events. I understand I can unsubscribe at any time.*

    When you provide the information above, we will use it to process your request as described in our Privacy Policy .

    Related Posts

    Midlands — UK Regional Labour Market Trends, June ... As the largest regional economy in the UK, what recruitment trends have we seen in the Midlands so far in 2022? Which sectors saw the most growth, and...
    Engineering vacancies set to reach record high due... Need for innovation in life sciences means engineering vacancies in Europe are likely to hit record levels in 2022 Pharmaceuticals have the lion’s sh...